Further work is required to elucidate whether Cav1-dependent resistance-promoting signals from ECs can be separated from Cav1-dependent stromal signals that restrict tumor growth and may thus allow a safer targeting of Cav1 mediated radiation resistance. The gene discussed is CAV1; the disease is neoplasm.